Background/Aims: Inflammatory response is a determinant in the pathological progression of acute pancreatitis (AP). Previous studies have shown that the activation of hedgehog (Hh) signaling is a remarkable change in caerulein-induced AP. However, the relationship between Hh signaling and inflammation is largely ambiguous. Methods: The AP mouse model was induced by injection of cerulein, and histological staining and serum enzymology assays were used to evaluate the establishment of AP. Western blot assay was used to determine the protein levels, cleavage of apoptotic proteins, and activation of the NF-kB signaling pathway. Cytokine array was used to screen inflammatory cytokines, and target cytokines' transcriptional expression and serum levels were examined by real-time PCR and enzyme-linked immunosorbent assay, respectively. Results: The key transcriptional factor in Hh signaling, Gli2, was upregulated in the pancreas and other tissues during the process of AP, and it seems to be a characteristic feature of local inflammation in pancreatic tissue and systemic inflammatory response in multiple organs. The inflammatory NF-κB pathway is required for the activation of Hh signaling, as blockade of the NF-κB pathway by pyrrolidine dithiocarbamate impaired the Gli2 upregulation. Manipulation of Gli2 expression altered the activation of the NF-κB pathway correspondingly, as well as the cell apoptosis in cerulein-induced AP. Moreover, Gli2 upregulation changed the cytokine expression profile in mouse pancreatic acinar cells, mainly decreasing the pro-inflammatory cytokines interleukin (IL)-6, interferon-g, and FasL. The anti-inflammatory cytokine IL-10 was upregulated by Gli2 overexpression. Interdiction of Gli2 by the Gli-specific inhibitor GANT61 exacerbated AP in mice and altered the balance of inflammatory cytokines. Conclusions: This study indicates that Hh activation during AP development is a negative feedback of the inflammatory response, restricting inflammatory injury to the pancreas and other tissues. Thus, manipulation of Hh signaling should shed light on limiting inflammation and alleviating AP damage.
Cytokine array and ELISA Cytokine arrays were carried out as previously reported [10] . Briefly, the supernatants were collected from cultures of 266-6 cells transfected with Gli2-expressing plasmid for 24 h. The arrays (RayBiotech, Norcross, GA, USA) were incubated with supernatant and protein spots were detected and quantified by autoradiography according to the manufacturer's instructions. The value of the scans was adjusted based on the intensity of positive control spots on each membrane by using MultiGauge V3.0 software (Fujifilm, Tokyo, Japan). Cytokine levels in 266-6 culture media were measured by a quantitative ELISA kit (Peprotech, Rocky Hill, NJ, USA) according to the manufacturer's instructions.
Real-time PCR
Total RNA was isolated from fresh tissue (pancreas, liver, lung, small intestine, kidney) or 266-6 cells using TRIzol reagent (Invitrogen, Carlsbad, CA, USA), and 2 µg of total RNA was reverse transcribed using reverse transcriptase. One microliter of the final cDNA was used for real-time PCR amplification with SYBR Green using a StepOne Plus real-time PCR system (Applied Biosystems, Foster City, CA, USA) and the cDNAs were amplified using the primers listed in Table 1 .
Western blot
Western blot was carried out as previously described [11] . The NE-PER Nuclear and Cytoplasmic Extraction kit (ThermoFisher, Shanghai, China) was used to isolate the cytoplasmic and nuclear protein fractions. Briefly, fresh tissue or cells were lysed using 1× lysis buffer (Cell Signaling Technology, Danvers, MA, USA), and 50 µg of total protein was separated via electrophoresis in a 4-12% gel. The proteins were then transferred onto a nitrocellulose membrane, followed by incubating the membrane with primary antibodies at 4°C overnight, washing, and then incubating with secondary antibodies at room temperature for 1 h. After washing, the immunoblot was developed using a chemiluminescence substrate (Thermo Fisher Scientific). The Gli2, Gapdh, Lamin B, and actin antibodies were from Santa Cruz Biotechnology; the NF-kB p65, p-p65, cleaved caspase-3, cleaved PARP, p-IkB-a, and IkB-a antibodies were from Cell Signaling Technology. The gray-scale images of the blots were analyzed using MultiGauge V3.0 software, and the protein levels calculated relative to the mock control (shown as the numbers under the blots in the figures) using actin or Gapdh as an internal control. 
Statistical analysis
Experimental values are expressed as mean ± standard error of the mean if not otherwise indicated. Statistical significance was analyzed using SPSS 17.0 software (SPSS Inc., Chicago, IL, USA) and determined by unpaired Student's t tests and one-way analysis of variance, and the survival rate was analyzed using Kaplan-Meier analysis. P < 0.05 was considered statistically significant. All results were reproduced in at least three independent experiments.
Results

Gli2 is upregulated in the mouse AP model
Intraperitoneal injection of cerulein was used to induce the mouse AP model and control mice (mock group) received PBS injection, as we reported previously [9] . The specimens were collected for histologic examination after the animals were euthanized. As shown in Fig. 1A , hematoxylin and eosin staining revealed that cerulein injection triggered the characteristic pathological changes of AP. In contrast to the nearly normal pancreas in the control group, cerulein administration led to interstitial edema, acinar vacuolization, inflammatory cell infiltration, and pancreatic necrosis. Consistent with these observations, the activities of myeloperoxidase (MPO) increased by 7.4-fold in mice injected with cerulein compared with the control group (Fig. 1B) . MPO is released by active neutrophils in the inflamed tissue, making pancreatic MPO activity a good indicator of inflammatory cell infiltration. In addition, serum amylase and lipase activities in the AP group were significantly elevated by 12.5-fold and 4.3-fold, respectively, compared with those in the control groups (Fig. 1B) .
In parallel with the pathological progress of AP, immunohistochemical assay showed that Gli2, a critical ingredient of Hh signaling, was markedly upregulated in pancreatic acinar cells of the AP group (Fig. 1C) . By using western blotting assay to detect the Gli2 protein level, we also found that its expression increased substantially in the AP pancreatic tissues compared with the mock control (Fig. 1D) . Furthermore, real-time PCR revealed that the downstream targets of the Hh pathway, Gli1, Ptch1, and Ccnd1 genes, were upregulated by 5.3-, 4.3-, and 6.2-fold, respectively, compared with the control (Fig. 1E) . Taken together, these results indicate that Hh signaling is activated during the development of ceruleininduced AP in mice. 
Gli2 is upregulated in other tissues of AP mice
Severe AP leads to systemic inflammatory response syndrome and multi-organ disorders, contributing to high morbidity and mortality. Hence, we further investigated whether Hh signaling activation is a feature of systemic inflammation and organ dysfunction. Immunohistochemical examination was performed to detect the Gli2 expression in vivo in lung, liver, small intestine, and kidney. After the induction of AP by cerulein injection, the expression of Gli2 protein markedly increased in multiple organs and was found mainly in the nucleus, suggesting an activation of Hh signaling ( Fig. 2A) . Real-time PCR assay further indicated that Gli2 mRNA was upregulated by 6.2-fold in lung, 4.7-fold in liver, 8.9-fold in small intestine, and 9.7-fold in kidney of AP mice compared with the control (Fig. 2B) . Western blot also validated the upregulation of Gli2 protein in these organs (Fig. 2C) . These results suggest that Gli2 upregulation is not only a feature of local inflammation in pancreatic tissue, but also a marker of systemic inflammatory response and tissue injury.
NF-κB pathway contributes to Gli2 upregulation
We next examined Gli2 expression in the murine acinar pancreatic cell line 266-6 treated with cerulein to mimic AP in vitro. After exposure to up to 3 mM cerulein for 24 h, the Gli2 mRNA increased up to 20-fold over that of control in a dose-dependent manner (Fig. 3A) . Furthermore, the Gli2 protein level increased in response to increasing concentrations of cerulein as well (Fig. 3B) . The inflammatory NF-κB signaling pathway was also activated by cerulein treatment, as the phosphorylation of the NF-kB subunit p65 (p-p65) increased with increasing cerulein concentration, as well as that of the antagonist of NF-kB signaling, IkB-a (p-IkB-a) (Fig. 3C) . Phosphorylation of IkB-a leads to its ubiquitination and proteasomal degradation, freeing NF-κB/REL complexes and activating the NF-kB signaling pathway.
In addition, NF-kB (p65) in the nucleus increased gradually, but the cytoplasmic NF-kB decreased accordantly, which indicated the obvious cyto-nuclear translocation (Fig. 3D) . These findings demonstrated that Gli2 upregulation is a cellular response to cerulein, and there might be a functional association between Gli2 and NF-κB. We further explored the mechanisms underlying Gli2 upregulation. Pyrrolidine dithiocarbamate (PDTC) was utilized to abrogate the inflammatory NF-κB pathway. We found that PDTC impaired NF-κB activation to a certain degree, but dramatically reversed the increase in Gli2 and p-p65 in the presence of 3 mM cerulein (Fig. 3E) . Thus, our results suggest that Gli2 is a marker of cerulein-induced AP, and the upregulation of Gli2 in AP is dependent on NF-kB activation.
Manipulation of Gli2 altered the activation of the NF-κB pathway in cerulein-induced AP
To further ascertain the role of Gli2 activation in cerulein-induced AP, we established acinar pancreatic 266-6 cells transiently expressing Gli2. Western blotting assay showed that the Gli2 protein level was successfully elevated after transfecting the Gli2-expressing plasmid (Gli2-OE) (Fig. 4A, upper panel) . Gli2 overexpression had virtually no effect on the basal level of NF-κB protein; however, the inducible level of p-p65 in cerulein treatment was extensively blocked by the forced expression of Gli2 (Fig. 4A) . Moreover, Gli2-overexpressing cells were more resistant to cerulein-induced apoptosis, as the apoptotic rate in these cells decreased from 33% to 20% (P < 0.01) as estimated by flow cytometric analysis using annexin V-FITC and propidium iodide staining (Fig. 4B) . Western blot showed that cerulein treatment effectively induced PARP and caspase-3 cleavage in the control cells, while Gli2 overexpression in 266-6 cells substantially decreased the extent of cleavage (Fig. 4C) . In contrast, when Gli2 was knocked down using Gli2-shRNA (Gli2-KD), the level of p-p65 induced by cerulein treatment was enhanced (Fig. 4D) , the apoptotic rate in the Gli2-KD cells was significantly augmented from 37% to 74% (P < 0.01) (Fig. 4E) , and the level of cleaved PARP and caspase-3 increased (Fig. 4F) . Therefore, Gli2 seems to be a protective factor in the cerulein-induced inflammation. 
Gli2 overexpression reduces the cytokine expression profile
To further examine the effect of Gli2 on pancreatic inflammation, we performed cytokine arrays to screen for alterations in cytokine expression. Representative images of cytokine arrays in Fig. 5A show that Gli2 overexpression dramatically changed the cytokine expression profile in murine pancreatic acinar cells. Gli2 overexpression effectively decreased the pro-inflammatory cytokines IL-6, IFN-g, and FasL (Fig. 5B) . At the same time, Gli2 also triggered an increase in anti-inflammatory cytokines such as IL-10. However, Gli2 also enhanced the expression of some pro-inflammatory cytokines such as G-CSF and MIG (Cxcl9). Obviously, the outcome of Gli2 activation can be ascribed to a comprehensive effect of multiple cytokines affected by Gli2. Real-time PCR further confirmed the array results and showed that the mRNA levels of three cytokines, IL-10, IFN-g, and FasL, were greatly altered by Gli2 overexpression (Fig. 5C ). IL-10 is an anti-inflammatory cytokine, FasL belongs to the TNF family and its binding with the receptor induces cell apoptosis, and IFN-g is an important inflammation inducer. Thus, we hypothesized that Gli2 overexpression inhibits inflammation.
Gli2 antagonism exacerbates pancreatic injury
The overall effect of Gli2 overexpression is cell protective and anti-inflammatory in cultured 266-6 cells, as mentioned above. Gli2 also alters the expression of anti-inflammatory and pro-inflammatory cytokines. We speculated that activation of Hh signaling and inducible expression of Gli2 in AP is beneficial to limit local inflammation. To test this assumption, we utilized GANT61, a specific inhibitor for Gli transcriptional factors, in the cerulein-induced AP model. As shown in Fig. 6A , the extent of cell edema and inflammatory cell infiltration in the cerulein plus GANT61 group was more pronounced compared with the AP and control groups. Thus, the AP development in mice co-treated with cerulein plus GANT61 was more extensive than that in the group treated with cerulein alone. Furthermore, GANT61 successfully antagonized the increase in Gli2 in the presence of cerulein (Fig. 6B) . As predicted, lipase and amylase levels were obviously higher in the cerulein plus GANT61 group when compared with the untreated or cerulein-treated group (Fig. 6C) . Additionally, Gli suppression decreased the survival rate in mice with AP (Fig. 6D) . Collectively, these results show that Gli inhibition by GANT61 aggravated cerulein-induced pancreatic injury. Further experiments indicated that GANT61 treatment enhanced the expression of inflammatory cytokines IFN-γ, FasL, IL-6, and TNF-α (Fig. 7A-D, respectively) as determined by enzyme-linked immunosorbent assay (ELISA). The secretion of G-CSF was slightly lower in the GANT61-treated group compared with the AP group (Fig. 7E) . In contrast, IL-10 expression was significantly inhibited by GANT61 (Fig. 7F) . Collectively, these results show that Gli inhibition altered the inflammation-associated cytokine profile, possibly accounting for the greater pancreatic injury.
Discussion
Most cases of AP start as a local and self-limiting inflammation of pancreatic tissue with only a brief need of clinical support. However, approximately 10-15% of patients develop severe AP and of those, 10-30% may die due to increases in systemic inflammation and dysfunction in multiple extrapancreatic organs. The variability in inflammatory responses could be a crucial determinant of the severity of AP. However, it remains unclear how the acinar cell injury from the initial inciting event results in local inflammation and its escalation into systemic inflammation [1, 2] .
An increasing number of experimental studies have implicated NF-κB activation in AP as an early and important event in the progression of inflammation [5] . NF-κB might be a central molecule that links the initial acinar injury to systemic inflammation and perpetuate the inflammation. It is well established that the expression and activity of NF-κB subunits such as p65 are upregulated in experimental and clinical AP. NF-κB activation during AP is capable of producing a considerable variety of cytokines such as TNF-α, IL-1, IL-2, IL-6, and IL-18, various chemokines such as IL-8 and MCP-1, and adhesion molecules. Several experimental AP models have clearly shown that pancreatic acinar cells produce cytokines via activation of NF-κB. NF-κB inhibition in the AP mouse model reduced the cytokine expression and local injury. The cytokines released from acinar cells after NF-κB activation in turn initiate the infiltration of neutrophils and lymphocytes into the pancreas and intestinal tracts, thereby amplifying the inflammatory response. Thus, the activation of the NF-κB pathway is intensified and expanded. As a positive feedback, NF-κB activation in acinar cells produces pro-inflammatory cytokines, specifically TNF-α and IL-1β, which have an emerging role in driving the pancreatic inflammation to systemic inflammation [3, 4] . Therefore, direct NF-κB inhibition strategies have already been attempted to alleviate pancreatic and systemic injury in animal AP models. Some agents such as aspirin, ω-3 fatty acids, fentanyl, and castanospermine have been shown to protect mice from severe pancreatitis and complications by inhibiting NF-κB activity [12] [13] [14] [15] .
In this study, we revealed a novel crosstalk between NF-κB signaling and Hh signaling. It is well established that Hh signaling participates in fate determination of the gut tube, as well as in early pancreatic development and islet cell function. Deregulation of Hh signaling also contributes to the pathogenesis and progression of pancreatic diseases, including diabetes mellitus, pancreatitis, and pancreatic cancer [7, 8] . Previous studies have demonstrated that the expression of the Hh signaling molecules, such as Shh, Ptch1, and Smo, was nearly absent in normal pancreatic tissues, and in the context of experimental AP, the Hh pathway members were greatly augmented, indicating a potential link between Hh signaling and the severity of AP [9, [16] [17] [18] . In this study, we found that Gli2, a crucial activator of Hh signaling, was greatly upregulated in damaged pancreas and other tissues such as lung, liver, small intestine, and kidney. Seemingly, Gli2 upregulation in the process of AP can reflect local inflammation in pancreatic tissue, and systemic inflammatory response in other organs. We further revealed that the upregulation of Gli2 is a result of inflammation-associated NF-κB activation. Antagonism of NF-κB by PDTC inhibited this Gli2 upregulation.
The roles of Hh signaling in inflammation remain controversial. Local inhibition of the Hh pathway facilitated endoneurial and perineurial vascular permeability following trigeminal nerve injury, thereby facilitating immunocyte infiltration and neuroinflammation [19] . Shh expression was gradually increased in the MPTP (1-methyl-4-phenyl-1, 2,3, 6-tetrahydropyridine) model of Parkinson's disease, and was involved in the recovery from neurotoxin-induced injury [20] . It was found that Shh protected dopaminergic neurons and attenuated the inflammatory response by stimulating the PI3K/Akt pathway and increasing the expression of transforming growth factor-β (TGF-β) [21] . The induction of immunemodulatory IL-10 and CD4
+
Foxp3
+ regulatory T cells is required for the protective effect of the Hh pathway in colitis [22] . Disruption of Hh signaling in inflammatory bowel disease fostered chronic intestinal inflammation. Associated mechanisms included downregulating inflammatory cytokines, and repressing monocyte chemo-attraction and fibroblast proliferation. Hh blockade increased the abundance of TNF-α, IL-17, and TGF-β [23] . However, Hh signaling was found to promote the induction and progression of inflammation and neoplastic transformation in infection with the pathogen Helicobacter pylori [24] . Shh has also been shown to positively regulate the expression of cytokines during H. pylori infection, such as IL-12, IL-1β, IL-10, IFN-γ, and MIP-2 [25] . Moreover, exogenous Shh could amplify the production of IL-2, IFN-γ, and IL-10 in activated CD4 + T cells [26] . As for AP, solid evidence has shown that the Hh pathway plays a protective role. Our previous studies found that neutralizing Shh caused more severe AP injury in mice. Another report indicated that Gli1 activity is required for pancreas recovery [27] . Deletion of a single allele of Gli1 caused improper stromal remodeling and persistence of the inflammatory infiltration, and hampered fibroblast migration. Mechanistic insight showed that partial loss of Gli1 downregulated a subset of cytokines including IL-6, IL-8, MCP-1, and M-CSF. In the case of chronic pancreatitis, the Hh pathway was found to interact with pancreatic stellate cells, leading to destructive parenchymal fibrosis and atrophy, as well as to irregular tissue remodeling with an increase in tumorigenesis [7, 28] . In this study, we validated the positive roles of Gli2 in AP. Gli2-overexpressing acinar cells exhibited greater potency to counteract cerulein-induced apoptosis, as evaluated by flow cytometric analysis. Our studies further demonstrated that Gli2 overexpression compromised NF-κB activation in cerulein-induced inflammation. Thus, it seems that Gli2 upregulation responding to NF-κB activation produces a negative feedback Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry to limit NF-κB activity and associated inflammation. However, an important point to be emphasized is that Gli1 and Gli2 are both transcriptional factors of hedgehog signaling and their expression increased in the AP mice. Because we used GANT61, an inhibitor of both Gli1-and Gli2-induced transcription, we cannot exclude a partial contribution of Gli1. Our further investigation revealed the complexity of Gli2 in modulating inflammation. The analysis of the cytokine profile in Gli2-overexpressing acinar cells revealed that several pro-inflammatory cytokines including IL-6, IFN-g, and FasL were downregulated, which may contribute to the protective roles of Gli2. Interestingly, Gli2 also upregulated the expression of anti-inflammatory cytokine IL-10 as well as pro-inflammatory G-CSF and MIG. These results suggest that Hh signaling and Gli transactivators may exert different effects on the distinct aspects of AP such as injury, inflammation, and repair. However, the precise mechanism and phase of Gli action remain elusive. Further investigation is required to draw a more nuanced picture of the functional aspects of the Hh pathway or Gli activators in AP.
In summary, our study emphasizes the protective function of Hh signaling in AP and proposes a role of Gli2 upregulation as a marker for local and systemic inflammation. An altered cytokine profile after Gli2 upregulation paves the path for cell defense against inflammatory injury. Thus, manipulating the Hh pathway might be an effective therapeutic guideline for clinical AP treatment.
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